Menglin Wang
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Analytical chemistry methods development 5
-
- Nanoplatforms for cancer theranostics 14
Menglin Wang
55 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Biomaterials 727
- Biomedical Engineering 1.1k
- Immunology 281
- Cancer Research 181
- Hepatology 95
Countries citing papers authored by Menglin Wang
This map shows the geographic impact of Menglin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Menglin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Menglin Wang more than expected).
Fields of papers citing papers by Menglin Wang
This network shows the impact of papers produced by Menglin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Menglin Wang. The network helps show where Menglin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Menglin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 13 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 19 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 18 | |
| 8 | 2023 | 44 | |
| 9 | 2023 | 22 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 2 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 50 | |
| 14 | 2021 | 43 | |
| 15 | 2021 | 9 | |
| 16 | 2021 | 105 | |
| 17 | 2020 | 141 | |
| 18 | 2020 | 106 | |
| 19 | Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy Hit paper breakdown → | 2018 | 370 |
| 20 | Effects of the combination of As2O3 and AZT on proliferation inhibition and apoptosis induction of hepatoma HepG2 cells following silencing of Egr-1 | 2018 | 1 |
About Menglin Wang
Menglin Wang is a scholar working on Analytical Chemistry, Biomedical Engineering, Surfaces, Coatings and Films, Biomaterials and Pollution, having authored 59 papers that have together received 2.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (14 papers), Nanoparticle-Based Drug Delivery (5 papers), Immunotherapy and Immune Responses (5 papers), Analytical chemistry methods development (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Fiber-reinforced polymer composites (3 papers), Surface Modification and Superhydrophobicity (3 papers) and Toxic Organic Pollutants Impact (3 papers). The work is most often cited by research in Biomaterials (727 citations), Biomedical Engineering (1.1k citations), Immunology (281 citations), Cancer Research (181 citations) and Hepatology (95 citations). Menglin Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhonggui He, Jin Sun, Qiming Kan, Haotian Zhang, Bingjun Sun, Cong Luo, Xuanbo Zhang, Leaf Huang, Yongjun Wang and Qin Chen. Their work appears in journals such as Biomaterials, Journal of Controlled Release, Journal of materials research/Pratt's guide to venture capital sources, Science Advances and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.